Hepatocellular carcinoma causes: Difference between revisions
Jump to navigation
Jump to search
| Line 17: | Line 17: | ||
*[[Tyrosinemia]] type 1 | *[[Tyrosinemia]] type 1 | ||
==Less common causes== | ==Less common causes== | ||
Common causes of hepatocellular carcinoma include the following:<ref name="AgostiSabbà2018">{{cite journal|last1=Agosti|first1=Pasquale|last2=Sabbà|first2=Carlo|last3=Mazzocca|first3=Antonio|title=Emerging metabolic risk factors in hepatocellular carcinoma and their influence on the liver microenvironment|journal=Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease|volume=1864|issue=2|year=2018|pages=607–617|issn=09254439|doi=10.1016/j.bbadis.2017.11.026}}</ref> | Common causes of hepatocellular carcinoma include the following:<ref name="AgostiSabbà2018">{{cite journal|last1=Agosti|first1=Pasquale|last2=Sabbà|first2=Carlo|last3=Mazzocca|first3=Antonio|title=Emerging metabolic risk factors in hepatocellular carcinoma and their influence on the liver microenvironment|journal=Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease|volume=1864|issue=2|year=2018|pages=607–617|issn=09254439|doi=10.1016/j.bbadis.2017.11.026}}</ref><ref name="pmid29150490">{{cite journal |vauthors=Gerbes A, Zoulim F, Tilg H, Dufour JF, Bruix J, Paradis V, Salem R, Peck-Radosavljevic M, Galle PR, Greten TF, Nault JC, Avila MA |title=Gut roundtable meeting paper: selected recent advances in hepatocellular carcinoma |journal=Gut |volume=67 |issue=2 |pages=380–388 |year=2018 |pmid=29150490 |doi=10.1136/gutjnl-2017-315068 |url=}}</ref><ref name="pmid29128083">{{cite journal |vauthors=Didi-Kouko Coulibaly J, Yeboua M, Kouassi Mbengue A, Kouadio EA, Anzouan-Kacou Kissi H, Binan AY, Lohoues Kouacou MJ, Attia A, N'Drin DY, Toutou T, Adoubi I, Pineau P |title=Evolution of hepatocellular carcinoma epidemiology in Côte d'Ivoire |journal=Bull Cancer |volume=104 |issue=11 |pages=937–945 |year=2017 |pmid=29128083 |doi=10.1016/j.bulcan.2017.09.010 |url=}}</ref> | ||
*Non alcholic fatty liver disease(NAFLD) | *Non alcholic fatty liver disease(NAFLD) | ||
*Non alchoholic steatohepatitis(NASH) | *Non alchoholic steatohepatitis(NASH) | ||
Revision as of 16:33, 23 January 2018
|
Hepatocellular carcinoma Microchapters |
|
Differentiating Hepatocellular carcinoma from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Hepatocellular carcinoma causes On the Web |
|
American Roentgen Ray Society Images of Hepatocellular carcinoma causes |
|
Risk calculators and risk factors for Hepatocellular carcinoma causes |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Dildar Hussain, MBBS [2] Mohamad Alkateb, MBBCh [3]
Overview
Common causes of hepatocellular carcinoma include hepatitis B, hepatitis C, alcoholic liver cirrhosis, hemochromatosis, and hepatic porphyrias.
Common Causes
Common causes of hepatocellular carcinoma include the following:[1][2][3]
- Hepatitis B
- Hepatitis C
- Liver cirrhosis
- Aflatoxins
- Hemochromatosis
- Hepatic porphyrias (acute intermittent porphyria, porphyria cutanea tarda, hereditary coproporphyria, and variegate porphyria)
- Tyrosinemia type 1
Less common causes
Common causes of hepatocellular carcinoma include the following:[4][5][6]
- Non alcholic fatty liver disease(NAFLD)
- Non alchoholic steatohepatitis(NASH)
- Metabolic disorders:
- Diabetes mellitus type II
- Obesity
- Metabolic syndrome
- Gut microbiota[7]
Drugs
The carcinogenic drugs for hepatocellular carcinoma are:
References
- ↑ Jiang, Kun; Centeno, Barbara A. (2018). "Primary Liver Cancers, Part 2". Cancer Control. 25 (1): 107327481774465. doi:10.1177/1073274817744658. ISSN 1073-2748.
- ↑ Said, Adnan; Ghufran, Aiman (2017). "Epidemic of non-alcoholic fatty liver disease and hepatocellular carcinoma". World Journal of Clinical Oncology. 8 (6): 429–436. doi:10.5306/wjco.v8.i6.429. ISSN 2218-4333.
- ↑ Erkekoglu P, Oral D, Chao MW, Kocer-Gumusel B (2017). "Hepatocellular Carcinoma and Possible Chemical and Biological Causes: A Review". J. Environ. Pathol. Toxicol. Oncol. 36 (2): 171–190. doi:10.1615/JEnvironPatholToxicolOncol.2017020927. PMID 29199597.
- ↑ Agosti, Pasquale; Sabbà, Carlo; Mazzocca, Antonio (2018). "Emerging metabolic risk factors in hepatocellular carcinoma and their influence on the liver microenvironment". Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1864 (2): 607–617. doi:10.1016/j.bbadis.2017.11.026. ISSN 0925-4439.
- ↑ Gerbes A, Zoulim F, Tilg H, Dufour JF, Bruix J, Paradis V, Salem R, Peck-Radosavljevic M, Galle PR, Greten TF, Nault JC, Avila MA (2018). "Gut roundtable meeting paper: selected recent advances in hepatocellular carcinoma". Gut. 67 (2): 380–388. doi:10.1136/gutjnl-2017-315068. PMID 29150490.
- ↑ Didi-Kouko Coulibaly J, Yeboua M, Kouassi Mbengue A, Kouadio EA, Anzouan-Kacou Kissi H, Binan AY, Lohoues Kouacou MJ, Attia A, N'Drin DY, Toutou T, Adoubi I, Pineau P (2017). "Evolution of hepatocellular carcinoma epidemiology in Côte d'Ivoire". Bull Cancer. 104 (11): 937–945. doi:10.1016/j.bulcan.2017.09.010. PMID 29128083.
- ↑ Sanduzzi Zamparelli M, Rocco A, Compare D, Nardone G (2017). "The gut microbiota: A new potential driving force in liver cirrhosis and hepatocellular carcinoma". United European Gastroenterol J. 5 (7): 944–953. doi:10.1177/2050640617705576. PMC 5676553. PMID 29163959.